Therapeutic Asset Ratings
603 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Triamcinalone
Glioblastoma
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
Benadryl
Malignant Pleural Disease
Memorial Sloan Kettering Cancer Center
P1/2
CCC
(48)
Epirubicin
Malignant Pleural Disease
Memorial Sloan Kettering Cancer Center
P1/2
CCC
(48)
FULVESTRANT
Carcinoma
Memorial Sloan Kettering Cancer Center
P1/2
CCC
(48)
Icasp9M28Z T Cell Infusions
Pleural Cancer
Memorial Sloan Kettering Cancer Center
P1/2
CCC
(48)
Neratinib
Central Nervous System Neoplasm
Memorial Sloan Kettering Cancer Center
P1/2
CCC
(48)
Pembrolizumab
Pleural Cancer
Memorial Sloan Kettering Cancer Center
P1/2
CCC
(48)
Revumenib
Acute Leukemia
Memorial Sloan Kettering Cancer Center
P1/2
CCC
(48)
TRASTUZUMAB
Central Nervous System Neoplasm
Memorial Sloan Kettering Cancer Center
P1/2
CCC
(48)
Trastuzumab Emtansine
Central Nervous System Tumor
Memorial Sloan Kettering Cancer Center
P1/2
CCC
(48)
Devimistat
Lymphoma
Memorial Sloan Kettering Cancer Center
P2
CC
(47)
Eloxatin
Primary Central Nervous System Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
P1
CC
(47)
Epirubicin
Kaposi Sarcoma
Memorial Sloan Kettering Cancer Center
P1
CC
(47)
Pembrolizumab
Kaposi'S Sarcoma
Memorial Sloan Kettering Cancer Center
P1
CC
(47)
Tisagenlecleucel
Primary CNS Lymphoma
Memorial Sloan Kettering Cancer Center
P1
CC
(47)
Abemaciclib
MIT Family Translocation Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center
P1/2
CC
(47)
Bumetanide
Hepatocellular Carcinoma
Memorial Sloan Kettering Cancer Center
P1/2
CC
(47)
Icasp9M28Z T Cell Infusions
Metastatic Neoplasm
Memorial Sloan Kettering Cancer Center
P1/2
CC
(47)
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER
Metastatic Neoplasm
Memorial Sloan Kettering Cancer Center
P1/2
CC
(47)
Lorlatinib
Metastatic Neoplasm
Memorial Sloan Kettering Cancer Center
P1/2
CC
(47)
Nivolumab
Recurrent
Memorial Sloan Kettering Cancer Center
P1/2
CC
(47)
Pertzye
Exocrine Pancreatic Carcinoma
Memorial Sloan Kettering Cancer Center
P1/2
CC
(47)
2141-v11 antibody
Prostate Cancer
Memorial Sloan Kettering Cancer Center
P2
CC
(46)
68ga-hbed-ipsma
Prostate Cancer
Memorial Sloan Kettering Cancer Center
P2
CC
(46)
Degarelix
Plasma Cell Myeloma
Memorial Sloan Kettering Cancer Center
P2
CC
(46)
Showing 326 to 350 of 603 assets
Previous
Page 14 of 25
Next
